Regulation - Abraxane

Filter

Current filters:

Abraxane

Popular Filters

Celgene’s Abraxane gets positive CHMP opinion for pancreatic cancer

Celgene’s Abraxane gets positive CHMP opinion for pancreatic cancer

29-11-2013

US biotech company Celgene’s (Nasdaq: CELG) European subsidiary has received a positive opinion from…

AbraxaneCelgeneEuropeOncologyPharmaceuticalRegulation

US FDA backs Abraxane for metastatic pancreatic cancer

09-09-2013

US biotech firm Celgene (Nasdaq: CELG) said on Friday (September 6) that the US Food and Drug Administration…

AbraxaneBiotechnologyCelgenegemcitabine HclNorth AmericaOncologyRegulation

FDA Approves Abraxane for NSCLC and expands indication for Actemra

15-10-2012

The US Food and Drug Administration on Friday approved biotech firm Celgene's (Nasdaq: CELG) Abraxane…

AbraxaneActemraAnti-Arthritics/RheumaticsBiotechnologyCelgeneGenentechNorth AmericaOncologyPharmaceuticalRegulationRoche

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top